Novartis' Deal With Thais Averts License Battle

Sidestepping a potential high-profile battle over compulsory licensing, Swiss pharmaceutical giant Novartis AG has agreed to provide its cancer drug Glivec free of charge to most patients in Thailand....

Already a subscriber? Click here to view full article